'An acute hemodynamic study . . . was performed prior to the implant, which demonstrated a significant increase in cardiac output and decrease of pulmonary capillary wedge pressure' (1) Many heart failure specialists still believe that the pathophysiology of cardiac resynchronization therapy (CRT) is incompletely understood; however, it must be emphasized that the main effects of biventricular pacing have already been described more than a decade ago. 1 In 1994, Cazeau et al. 1 reported how biventricular pacing improves clinical signs and symptoms of heart failure, acutely increases cardiac output and decreases pulmonary capillary wedge pressure and that those effects were likely mediated by better synchronization of left ventricular (LV) mechanical contraction. However, despite the obvious clinical success of this novel therapeutic approach, the authors were very modest with speculations on the impact on mortality:
'We doubt that this technique will have an impact on long-term survival, but it could be of major importance to improve the patients well-being and control heart failure.' (1) Fortunately, this was the only false estimation at that time. The doubts with regard to the potential survival benefit were later refuted by the results of well controlled, randomized clinical trials which clearly demonstrated a reduced overall mortality in the CRT treatment arm 2 and which paved the way for a class I indication in symptomatic heart failure patients with a prolonged QRS complex of 120 ms or above. However, despite the undisputed success of CRT for this selected population, many questions remain. The non-responder rate of more than 30-40% is relatively high for such a costly and invasive therapy and has pushed investigators to search for new strategies to better identify CRT responders and to improve optimization of the device settings. However, there are many reasons that might explain CRT failure.
First, heart failure is a multifactorial disease with dyssynchrony representing only one aspect. Thus, a single therapy strategy might not 'cure' the entire disease process, in particular, not in patients who already have reached a 'point of no return'.
Secondly, important implantation criteria are often not met, above all, the presence of correctable mechanical dyssynchrony. In general, patients with a lesser degree of QRS widening (QRS,150 ms) tend to respond less favourably in terms of LV systolic function (estimated by peak positive LV dP/dt) and pulse pressure improvement during acute haemodynamic testing when compared with patients with more severe electrical dyssynchrony (QRS.150 ms). 3 We also learned that patients with a non-correctable cause for mechanical dyssynchrony (such as a myocardial scar) will benefit less from CRT. 4 Thirdly, even if the pre-implant assessment indicates that a patient is a perfect candidate for resynchronization, he might still not respond favourably if the LV stimulation site does not correspond to a delayed activated site or if the stimulation settings are suboptimal for his individual situation. Butter et al. 5 demonstrated that the haemodynamic response is lower during LV anterior and anterolateral pacing than during posterolateral pacing. But in many patients, the choice of an optimal stimulation site is limited by the anatomic variations of the cardiac veins with frequent ineffective or intolerable LV stimulation. Furthermore, there is still controversy about the optimal stimulation mode, i.e. single-site LV pacing vs. biventricular pacing and simultaneous vs. sequential biventricular pacing. Invasive studies have suggested that univentricular LV pacing may increase LV peak positive dP/dt even more than simultaneous biventricular pacing 3 and that sequential pacing may further increase haemodynamic function by additional 5-10% from baseline values. 6 However, it must also be noted that the impact of single-site LV pacing and of CRT 'fine-tuning' with sequential biventricular pacing on long-term outcome is still unclear and it seems that
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only a minority of patients benefit significantly. 7, 8 But for some individuals with a poor response to standard biventricular pacing, a device optimization procedure might be essential to improve the outcome. Furthermore, although biventricular pacing is usually better than the intrinsic left bundle branch block or right ventricular pacing, it is still far from optimal and it is important to remember that CRT also has the potential to worsen the haemodynamic situation compared with no pacing in some patients. 3 Therefore, the positive as well as the potential negative effects of biventricular pacing define our responsibilities in patient selection and follow-up. Most clinicans and, in particular, the affected patients would probably favour a noninvasive approach to improve the selection of CRT candidates and their follow-up assessment. After implantation of such a complex device, it is not sufficient to confirm the technical operability, but it is also mandatory to assure that the programmed settings have improved cardiac function. Patients with no evidence of mechanical and haemoynamic improvement might be candidates for a optimization procedure. Particular attention must be given when the follow-up assessment indicates deterioration of cardiac function.
In this context, the study by Tournoux et al. 9 reminds us that we should not blindly rely on the implanted CRT device without scrutinizing its impact on haemodynamics. The authors measured the acute increase in LV dp/dt (DdP/dt) by Doppler echocardiography as a relatively simple non-invasive test for the acute haemodynamic response after CRT implantation. Patients were classified as non-responders (DdP/dt,0%), poor responders (DdP/dt 0-25%) and high responders (DdP/dt.0%). Over a period of 12 months, a combined endpoint of hospitalization due to heart failure and all-cause mortality was followed. The study demonstrated in a small patient cohort that DdP/dt was the most powerful parameter to predict long-term outcomes in CRT patients. In addition, the authors were able to confirm the previously established link between the haemodynamic response and mechanical synchronization 10 
in this study by tissue Doppler imaging (TDI).
What are the implications from this study? First, a simple, non-invasive acute haemodynamic assessment within 24 h after implantation allows to predict the long-term CRT response. Such a test might also be performed even earlier within the operating theatre as an approach to predict longterm outcome before final device implantation. As a result, the implantation of a CRT system in a predicted nonresponder should be re-evaluated carefully in view of limited financial health care resources and the possible negative impact on the patient.
Secondly, no significant differences in outcome were observed in this study between patients with ischaemic or non-ischaemic cardiomyopathies. This is an important issue, as large trials indicated that improvement by CRT was better in non-ischaemic patients when compared with ischaemic patients, in particular, if a transmural scar is present in the target region of the LV lead, the lateral wall. 4 Unfortunately, the authors do not further comment on this observation, especially with regard to individual LV lead positioning, scar tissue, and anatomic configuration of the cardiac veins.
Thirdly, the results imply that a single measure of global LV function after device implantation may allow to predict the long-term CRT response. This single parameter can be obtained without advanced equipment for assessment of myocardial synchrony by TDI or 3D imaging and without time-consuming measurements of several parameters and calculations. However, such a non-invasive LV dP/dt estimation is frequently not feasible, in particular, not in patients without mitral regurgitation (in the present study only in 55% of the patients screened). In such patients without mitral regurgitation, more advanced methods are required to quantify the effects on global function and resynchronization. TDI has been studied extensively for this purpose and provides important predictive information to the experienced reader. However, TDI has mainly been tested for patient selection before implantation and its use during follow-up is less well established. Furthermore, it does not allow to differentiate between correctable and non-correctable causes of dyssynchrony like extensive scar tissue. 4 For this purpose, new methods for deformation imaging are currently under investigation. The most complete assessment of LV synchrony can probably be done by 3D imaging techniques, which also provide more reliable information on LV ejection fraction and volume changes, but which are not yet widely available.
In conclusion, the present study of Tournoux et al.
9
describes a relatively simple echocardiographic method to predict long-term response to CRT early after implantation. Although this parameter may not be feasible in every patient, it should be added to the routine diagnostic armamentarium and should be applied in suitable patients. CRT is likely to be beneficial, if a clear haemodynamic improvement can be documented after implantation, irrespective of the more complex mechanical response, as predicted already a decade ago:
'Selection of the optimal candidates for four chamber cardiac pacing remains to be defined. Although desynchronization of ventricular activation is a clear prerequisite, it must also be associated with a severe cardiac decompensation. Thus, the mere presence of a LBBB in a patient with compensated dilated cardiomyopathy probably does not justify this approach. Furthermore, it seems critical to establish carefully both angiographically and hemodynamically the presence of a correctable situation best manifested by a circulatory improvement when pacing ventricular segments suffering from delayed activation.' (1) Multiple myocardial abscesses successfully treated with medical management in an immunosuppressed patient Myocardial abscess is usually resulted from the septicemia of various microorganisms such as Candida, Staphylococcus, Aspergillus, Streptococcus, and Salmonella species. Since it is a potentially fatal complication which can cause myocardial rupture and death, surgical treatment is sometimes warranted. A 59-year-old man had a second cadaveric liver transplantation because of previous graft failure and received immunosuppressive therapy including FK506 and prednisolone. Twenty-four days after the surgery, chest X-ray showed rapidly progressive multiple nodular infiltrations in both lung fields. On chest computed tomography, the nodular infiltrations appeared to be cavity-forming lesions with central necrosis suggestive of fungal pneumonia, and multiple low-density round lesions were detected within the myocardium (upper panel). Transthoracic echocardiography showed echo-free spaces within the interventricular septum and midposterolateral wall (middle panel). Although no microorganism was identified by repeated microbiologic studies, empirical antibiotics and antifungal therapies were implemented. The myocardial abscesses were found to be decreased in size on the follow-up echocardiography after 20 days of medical management (lower panel), and he was uneventfully discharged from hospital 8 days after the echocardiography. Upper panel. Chest computed tomography showed a cavity-forming lesion in the right upper lobe suggestive of fungal pneumonia (arrow head) and multiple low-density round lesions within the myocardium (arrows).
Middle panel. Transthoracic echocardiography demonstrated multiple echo-free spaces suggesting abscesses within the myocardium of the interventricular septum and posterolateral wall (arrow heads).
Lower panel. On the follow-up echocardiography performed after 20 days of medical management, the myocardial abscesses were found to be decreased in size (arrow heads).
